Skip to main content
. Author manuscript; available in PMC: 2022 May 19.
Published in final edited form as: J Alzheimers Dis. 2022;87(1):415–432. doi: 10.3233/JAD-215657

Table 3.

Incidence density of ADRD by a history of CVD, stroke, hypertension, and diabetes in women with breast cancer with up to 26 years of follow-up from 1991 to 2016

Characteristics Incidence density of ADRD (number of ADRD cases per 1,000 person-years)
AD Vascular Lewy FTD MCI Others Total

Cardiovascular disease
 No 18.13 6.98 1.23 0.37 3.80 45.72 48.97
 Yes 30.83 14.12 1.50 0.30 4.16 86.33 92.41
Stroke
 No 18.19 6.78 1.20 0.36 3.58 45.66 48.87
 Yes 29.88 17.18 2.03 0.47 7.41 87.13 93.74
Hypertension
 No 17.07 6.08 1.13 0.33 3.09 39.62 42.46
 Yes 20.20 8.36 1.33 0.39 4.33 54.23 58.06
Diabetes
 No 18.38 6.89 1.21 0.36 3.62 45.09 48.26
 Yes 21.25 9.74 1.43 0.41 4.70 61.84 66.34
Age (years)
 65–69 6.93 2.96 0.65 0.27 2.32 22.35 24.41
 70–74 13.57 5.38 1.13 0.34 3.42 36.05 38.83
 75–79 22.63 8.94 1.56 0.44 4.66 55.12 58.8
 80–84 36.05 13.81 2.11 0.51 5.73 82.90 88.08
 85 or older 52.01 19.55 1.92 0.42 6.17 129.80 137.99
Race/ethnicity
 Whites 18.74 7.2 1.26 0.38 3.90 47.78 51.14
 Blacks 24.20 11.3 1.26 0.30 3.74 60.57 64.94
 Asians/Pacific Islanders 13.35 5.58 0.94 0.26 2.85 38.25 41.87
 Others 20.04 8.15 1.26 0.28 2.66 47.36 50.3
Marital status
 Married 14.09 5.18 1.12 0.32 3.40 36.02 38.81
 Unmarried 23.59 9.64 1.37 0.41 4.22 60.10 64.14
 Unknown 22.06 8.39 1.47 0.46 4.12 55.71 59.62
AJCC Tumor stage
 0 and I 17.17 6.63 1.21 0.36 3.97 42.21 45.34
 II 20.50 8.45 1.27 0.38 3.65 51.81 55.32
 III 21.07 7.8 1.35 0.34 3.50 63.60 67.89
 IV 19.96 7.44 0.88 0.19 3.01 91.21 97.39
 Unknown/Missing 30.13 11.43 1.68 0.44 3.52 74.06 79.04
Tumor size (cm)
 <1 15.90 6.2 1.21 0.36 4.01 39.36 42.46
 1–<2 18.10 7.03 1.19 0.37 3.85 44.54 47.6
 2–<3 20.00 8.33 1.30 0.36 3.60 51.11 54.75
 3–<4 23.19 8.58 1.39 0.34 3.46 61.51 65.35
 ≥4 22.72 9.06 1.31 0.39 3.96 64.04 68.57
 Missing 22.18 8.32 1.35 0.36 3.72 58.72 62.86
Tumor grade
 Well-differentiated 18.10 7 1.35 0.38 4.30 44.94 48.03
 Moderately-differentiated 18.46 7.2 1.23 0.38 3.84 46.64 49.99
 Poorly-differentiated 18.55 7.38 1.20 0.35 3.66 49.95 53.64
 Unknown/Missing 22.79 9.12 1.21 0.31 3.19 56.38 60.14
Hormone receptor status
 Positive 18.18 7.16 1.25 0.38 3.94 46.57 49.93
 Negative 17.98 6.95 1.18 0.34 3.78 48.51 51.99
 Unknown 24.20 9.48 1.33 0.34 3.15 57.95 61.71
Chemotherapy
 No 20.35 8 1.34 0.38 3.96 50.56 54.15
 Yes 12.57 4.88 0.83 0.32 3.20 37.96 40.65
Radiotherapy
 No 24.23 9.53 1.47 0.39 3.91 60.96 65.1
 Yes 14.61 5.72 1.07 0.35 3.74 37.93 40.77
Comorbidity Scores
 0 18.53 7.13 1.23 0.36 3.58 45.13 48.3
 1 19.94 8.17 1.32 0.40 4.88 58.64 62.88
 ≥2 25.35 12.72 1.59 0.49 5.36 86.57 93.2
SEER Areas
 Connecticut 21.80 14.04 1.14 0.47 3.76 52.37 56.12
 Detroit 26.06 11.07 1.26 0.35 2.99 57.03 60.33
 Hawaii 17.50 9.71 0.78 0.16 4.04 43.53 47.12
 Iowa 16.72 5.42 1.02 0.31 2.56 45.51 47.7
 New Mexico 16.58 5.74 1.33 0.32 2.91 47.89 50.15
 Seattle 14.07 6.04 0.73 0.25 2.41 35.78 38.91
 Utah 14.26 5.37 0.89 0.18 2.45 41.29 44.01
 Georgia 19.08 6.13 1.33 0.38 3.52 46.49 50.21
 Kentucky 21.57 6.67 1.53 0.43 2.74 57.01 59.26
 Louisiana 19.58 5.93 1.27 0.32 3.26 48.84 52.49
 New Jersey 20.80 8.43 1.43 0.48 4.61 50.60 54.93
 California 17.42 6.18 1.36 0.37 4.92 47.30 50.97
Total 18.92 7.43 1.25 0.37 3.82 48.24 51.66

ADRD, Alzheimer’s disease and related dementias; AD, Alzheimer’s disease; Vascular, vascular dementia; Lewy, dementia with Lewy bodies; FTD, frontotemporal degeneration and dementias; MCI, mild cognitive impairment; others, other dementias; total, any of above ADRD.